<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "glycopyrrolate inj VIAL>
<dose><value>0.1</value>
<value>0.2</value>
<value>0.005</value>
<value>4 - 10</value>
<value>3 - 5</value>
<value>4.4 - 8.8</value>
<value>4.4 - 10</value>
<value></value>
<value>0.2 - 0.6</value>
<value>0.8 - 2.4</value>
</dose><route><value>IM</value>
<value>IV</value>
<value>SC</value>
</route><form><value>inj VIAL</value>
</form><drugname><value>glycopyrrolate inj VIAL</value>
</drugname><strength><value>0.2 mg/mL</value>
</strength><frequency><value>Q4H</value>
<value>ONCE</value>
<value>Q3H</value>
<value>Q2H  </value>
<value>Q3H  </value>
<value>Q4H  </value>
<value>Q6H  </value>
<value>Q8H  </value>
<value>CONTINUOUS</value>
</frequency><instruction><value>for 3 doses.</value>
<value>for 4 doses.</value>
<value>30 minutes prior to anesthesia.</value>
<value>60 minutes prior to anesthesia.</value>
<value></value>
<value>Administer by direct injection.</value>
<value>Administer by direct injection, repeating as required at 2 to 3 minute intervals for intra-operative requirements.</value>
<value>Administer by continuous subcutaneous infusion.</value>
</instruction><volume><value>1 mL</value>
<value>2 mL</value>
<value>20 mL</value>
</volume><units><value>mg</value>
<value>mg/kg</value>
<value>mcg/kg/dose</value>
<value>mcg/kg </value>
<value>mcg/kg</value>
<value>mg/day</value>
</units><additionalnotes><value>Gastroenterology</value>
<value>Pre-anesthetic</value>
<value>Control of secretions.</value>
<value>Pre-anesthetic. MAXIMUM dose: 0.1 mg</value>
<value>Neuromuscular blockade reversal. 0.2 mg for each 1 mg of neostigmine or 5 mg of pyridostigmine.</value>
<value></value>
<value>Intra-operative. MAXIMUM dose: 0.1 mg</value>
<value>Palliative Care</value>
</additionalnotes><population><value>ADULT</value>
<value>CHILDREN</value>
<value>NEONATE</value>
<value>CHILDREN, 2 years of age and younger.</value>
<value>CHILDREN, 2 years of age and older.</value>
<value>ADULT / CHILDREN</value>
</population><indicationprn><value></value>
<value>to reduce upper airway secretions.</value>
</indicationprn><backgroundinformation><value></value>
<value>Contains Benzyl Alcohol</value>
</backgroundinformation><prninformation><value></value>
<value>YES</value>
</prninformation><ahsformularystatus><value>Formulary.</value>
</ahsformularystatus><ahfsname><value>Anticholinergic Agents</value>
</ahfsname><highalert><value></value>
</highalert><maximumprndose><value></value>
</maximumprndose></drug>